The authors concluded, "Kardia 6L (is) superior to the single-lead devices." About KardiaMobile 6L The KardiaMobile 6L device is the first and only six-lead personal ECG cleared by the FDA.

In less than a month, AliveCor plans to release its KardiaMobile 6L, which will provide 6 ECG leads using a smartphone-based mobile ECG system that is similar to the Kardia single-lead system.

The Kardia Mobile 6L is your own personal EKG monitor and can detect up to six of the most common arrhythmias: Atrial Fibrillation, Bradycardia, Tachycardia, Sinus Rhythm with Supraventricular Ectopy, ...

KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection, more insights, and ongoing access to board-certified cardiologist ECG reviews.

Kardia is the first AI-enabled platform to aid patients and clinicians in the early detection of atrial fibrillation, the most common arrhythmia and one associated with a highly-elevated risk of ...

SLOUGH, England, Aug. 30, 2019 /PRNewswire/ -- AliveCor announced today the UK launch of KardiaMobile 6L, the world's first FDA-cleared and CE-marked, six-lead personal heart monitoring device.

AliveCors KardiaMobile and KardiaMobile 6L devices, along with the Kardia app, allow users to take a 30-second ECG and receive instant determinations of multiple cardiac conditions.

KardiaMobile® 6L is the first smartphone-based personal electrocardiogram (ECG) to be conditionally recommended by the National Institute for Health and Care Excellence (NICE) as part of its ...

Hauser, who is retired from regular practice at the Minneapolis Heart Institute, has been using a wireless, consumer-oriented device called the Kardia Mobile to test his friends when they complain ...

Providing in-depth reporting on ECGs, blood pressure, and weight data with remote access to board-certified cardiologists, KardiaMobile 6L Max includes a KardiaMobile 6L Max ECG device and a one ...